We are pleased to announce Dr. Mark Moehle, Ph.D., has been awarded the 2026 Division for Neuropharmacology Early Career Award!
Dr. Moehle is receiving this award in recognition of his record in research, teaching, mentoring, and service.
Mark Moehle is an Assistant Professor of Pharmacology & Therapeutics at the University of Florida College of Medicine. He earned his Ph.D. at the University of Alabama at Birmingham in the lab of Andrew West where he focused on the mechanism behind how mutations in LRRK2 and alpha-synuclein pathology lead to Parkinson’s disease. He then did a postdoc at Vanderbilt University with P. Jeffrey Conn where he focused on muscarinic acetylcholine receptor pharmacology while adding electrophysiology to his skillset. As a faculty he has combined his doctoral and postdoc work to understand how alpha-synuclein pathology changes electrical properties of cortical and striatal neurons and how cholinergic signaling influences these changes with the goal of generating novel therapeutic strategies for Parkinson’s disease and other movement disorders.
Please join us in congratulating Dr. Moehle for this achievement!
